Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.21.2
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Total revenue $ 328,459 $ 37,680 $ 3,098,661 $ 528,052
Revenue from Contract with Customer, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Costs and expenses:        
Research and development $ 3,154,553 $ 120,569 $ 7,968,846 $ 666,858
Selling, general and administrative 1,644,946 580,820 4,854,494 1,478,839
Total costs and expenses 4,799,499 701,389 12,823,340 2,145,697
Loss from operations (4,471,040) (663,709) (9,724,679) (1,617,645)
Interest expense (157) (6,890) (19,765) (22,263)
Net loss $ (4,471,197) $ (670,599) $ (9,744,444) $ (1,639,908)
Net loss per share – basic and diluted $ (0.18) $ (0.08) $ (0.61) $ (0.20)
Weighted-average number of common shares – basic and diluted 25,143,559 8,198,754 15,868,421 8,187,517